Clinical Trials Specialist Degree Apprenticeships website is now live!

The pharmaceutical industry is undoubtedly a major contributor to the UK economy, whilst also providing and developing life-saving and life enhancing medicines to patients. However, in recent years many within the industry have witnessed a lack of skilled young researchers entering the profession. For the pharmaceutical sector to prevail (especially in such turbulent times) it

Continue Reading

Positive results for AZ’s type 2 diabetes trial

AstraZeneca has reported positive results from the Phase III DECLARE-TIMI 58 cardiovascular (CV) outcomes trial (CVOT) of BMS-512148 compared to placebo for the treatment of patients with type 2 diabetes (T2D). The trial had met its primary safety objective of non-inferiority for major adverse cardiovascular events (MACE). The trial also achieved one of its two

Continue Reading

Lilly commences plaque psoriasis treatment head to head trial

Eli Lilly and Company (Lilly) has commenced the IXORA-R head-to-head (H2H) clinical trial to investigate the efficacy and safety of ixekizumab when compared to guselkumab to treat adult patients with moderate-to-severe plaque psoriasis. Roughly 960 patients are expected to be included in the 24-week, multicentre, randomised, blinded, parallel-group trial. The trial’s primary objective is the

Continue Reading